Prognostic value of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with non-small cell lung cancer receiving immune checkpoint inhibitors: a meta-analysis

OBJECTIVES: Derived neutrophil-to-lymphocytes ratio (dNLR) has recently been reported as a novel potential biomarker associated with prognosis of non-small cell lung cancer (NSCLC). However, evidence for the prognostic utility of dNLR in patients with NSCLC treated with immune checkpoint inhibitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tao, Hao, Lizheng, Yang, Xinyu, Luo, Changyong, Wang, Guomi, Lin Cai, Caroline, Qi, Shuo, Li, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413941/
https://www.ncbi.nlm.nih.gov/pubmed/34475167
http://dx.doi.org/10.1136/bmjopen-2021-049123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413941/
https://www.ncbi.nlm.nih.gov/pubmed/34475167
http://dx.doi.org/10.1136/bmjopen-2021-049123

Ejemplares similares